NCT06235242 - GT201 Injection in Combination with Teraplizumab Injection for Treatment of Patients with Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

AdultNon-small Cell Lung Cancer

Interventions

BIOLOGICAL

GT201 injection in combination with teraplizumab injection

GT201 injection in combination with teraplizumab injection for treatment of patients with non-small cell lung cancer

Trial Locations (3)

NOT_YET_RECRUITING

Shanghai East Hospital, Shanghai

RECRUITING

Shanghai GoBroad Cancer Hospital, Shanghai

RECRUITING

Beijing Gobroad Hospital, Beijing